United Kingdom· GB-APID-41138611000001105
Giapreza 2.5mg/1ml concentrate for solution for infusion vials
A angiotensin ii product containing angiotensin ii, registered in United Kingdom by PAION Pharma GmbH. The same ATC class is registered in 11 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Angiotensin ii is registered in 11 of 19 countries.
Countries holding a registration under ATC C01CX09 (angiotensin ii), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Angiotensin ii · ATC C01CX09
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Angiotensin II
- Manufacturer
- PAION Pharma GmbH
- Country
- United Kingdom (GB)
- ATC code
- C01CX09
- ATC class
- Angiotensin II
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin04260727580018
- gtin04260727580377
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Angiotensin ii in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesANGIOTENSIN IIGland Pharma Limited
- FranceGIAPREZA 2,5 mg/ml, solution à diluer pour perfusionPAION PHARMA (ALLEMAGNE)
- IcelandGiaprezaPAION Pharma GmbH
- SpainGIAPREZA 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSIONPaion Pharma Gmbh
- NorwayGiaprezaPAION Pharma GmbH
- SwedenGIAPREZA 2,5 mg/ml Koncentrat till infusionsvätska, lösningPAION Pharma GmbH
- NetherlandsGiapreza 2,5 mg/ml concentraat voor oplossing voor infusiePaion Pharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Giapreza
- Liechtenstein · Giapreza
- Norway · Giapreza
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d11a4b55-3ff7-48cf-96d0-8be1e79aad64 GET /v1/drugs/d11a4b55-3ff7-48cf-96d0-8be1e79aad64?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "41138611000001105",
"desc": "Giapreza 2.5mg/1ml concentrate for solution for infusion vials (PAION Pharma GmbH)",
"form": "Solution for infusion",
"vpid": "41140811000001107",
"source": "dmd",
"vtm_id": "774609006",
"strength": "2.5 mg",
"substance": "Angiotensin II",
"ingredient": "Angiotensin II acetate",
"supplier_code": "39862411000001101"
}See everything about angiotensin ii.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.